Piracetam reduces oxidative stress and mitochondrial function impairment in an in vitro model of vascular dementia

Cohen PA, Zakharevich I, Gerona R (2020) Presence of Piracetam in Cognitive Enhancement Dietary supplements. JAMA Intern Med 180:458–459. https://doi.org/10.1001/jamainternmed.2019.5507

Article  PubMed  Google Scholar 

Dichgans M, Leys D (2017) Vascular cognitive impairment. Circ Res 120:573–591. https://doi.org/10.1161/CIRCRESAHA.116.308426

Article  CAS  PubMed  Google Scholar 

Du SQ, Wang XR, Xiao LY, Tu JF, Zhu W, He T, Liu CZ (2017) Molecular mechanisms of vascular dementia: what can be learned from animal models of chronic cerebral hypoperfusion? Mol Neurobiol. 54:3670–3682. https://doi.org/10.1007/s12035-016-9915-1

Guan T, Xiao Y, Xie X, Meng N, Qi Q, Xu J, Lv P (2023) Dulaglutide improves gliosis and suppresses Apoptosis/Autophagy through the PI3K/Akt/mTOR signaling pathway in vascular dementia rats. Neurochem Res 48:1561–1579. https://doi.org/10.1007/s11064-022-03853-0

Article  CAS  PubMed  Google Scholar 

Hall ED, Von Voigtlander PF (1987) Facilitatory effects of piracetam on excitability of motor nerve terminals and neuromuscular transmission. Neuropharmacology 26:1573–1579. https://doi.org/10.1016/0028-3908(87)90003-7

Article  CAS  PubMed  Google Scholar 

Hosoki S, Hansra GK, Jayasena T, Poljak A, Mather KA, Catts VS, Sachdev PS (2023) Molecular biomarkers for vascular cognitive impairment and dementia. Nat Rev Neurol 19:737–753. https://doi.org/10.1038/s41582-023-00884-1

Article  CAS  PubMed  Google Scholar 

Keil U, Scherping I, Hauptmann S, Schuessel K, Eckert A, Muller WE (2006) Piracetam improves mitochondrial dysfunction following oxidative stress. Br J Pharmacol 147:199–208. https://doi.org/10.1038/sj.bjp.0706459

Article  CAS  PubMed  Google Scholar 

Li X, Ren C, Li S, Han R, Gao J, Huang Q, Ji X (2017) Limb remote ischemic conditioning promotes myelination by upregulating PTEN/Akt/mTOR signaling activities after chronic cerebral hypoperfusion. Aging Dis 8:392–401. https://doi.org/10.14336/AD.2016.1227

Article  PubMed  PubMed Central  Google Scholar 

Luan Y, Luan Y, Jiao Y, Liu H, Huang Z, Feng Q, Ren K (2023) Broadening Horizons: exploring mtDAMPs as a mechanism and potential intervention target in Cardiovascular diseases. Aging Dis. https://doi.org/10.14336/AD.2023.1130

Article  PubMed  PubMed Central  Google Scholar 

Malykh AG, Sadaie MR (2010) Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs 70:287–312. https://doi.org/10.2165/11319230-000000000-00000

Article  CAS  PubMed  Google Scholar 

Mindus P, Cronholm B, Levander SE, Schalling D (1976) Piracetam-induced improvement of mental performance. A controlled study on normally aging individuals. Acta Psychiatr Scand 54:150–160. https://doi.org/10.1111/j.1600-0447.1976.tb00107.x

Article  CAS  PubMed  Google Scholar 

Muley MM, Thakare VN, Patil RR, Bafna PA, Naik SR (2013) Amelioration of cognitive, motor and endogenous defense functions with silymarin, piracetam and protocatechuic acid in the cerebral global ischemic rat model. Life Sci 93:51–57. https://doi.org/10.1016/j.lfs.2013.05.020

Article  CAS  PubMed  Google Scholar 

Nasr M, Wahdan SA (2019) Neuroprotective effects of novel nanosystems simultaneously loaded with vinpocetine and piracetam after intranasal administration. Life Sci 226:117–129. https://doi.org/10.1016/j.lfs.2019.04.014

Article  CAS  PubMed  Google Scholar 

O’Brien JT, Thomas A (2015) Vascular dementia. Lancet 386:1698–1706. https://doi.org/10.1016/S0140-6736(15)00463-8

Article  PubMed  Google Scholar 

Rajeev V, Fann DY, Dinh QN, Kim HA, De Silva TM, Lai MK, P, Arumugam TV (2022) Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment. Theranostics 12:1639–1658. https://doi.org/10.7150/thno.68304

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verma DK, Gupta S, Biswas J, Joshi N, Singh A, Gupta P, Singh S (2018) New therapeutic activity of metabolic enhancer piracetam in treatment of neurodegenerative disease: participation of caspase independent death factors, oxidative stress, inflammatory responses and apoptosis. Biochim Biophys Acta Mol Basis Dis 1864:2078–2096. https://doi.org/10.1016/j.bbadis.2018.03.014

Article  CAS  PubMed  Google Scholar 

Wolters FJ, Ikram MA (2019) Epidemiology of vascular dementia. Arterioscler Thromb Vasc Biol 39:1542–1549. https://doi.org/10.1161/ATVBAHA.119.311908

Article  CAS  PubMed  Google Scholar 

Xiao H, Peng D, Guo YJE, J o G, O (2023) CENPF facilitates endometrial cancer cell progression through PI3K/AKT/mTOR pathway. Eur J Gynaecol Oncol 44:106–114

Google Scholar 

Xu P, Li M, Bai Y, Lu W, Ling X, Li W (2015) The effects of piracetam on heroin-induced CPP and neuronal apoptosis in rats. Drug Alcohol Depend 150:141–146. https://doi.org/10.1016/j.drugalcdep.2015.02.026

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif